Ildong Pharmaceutical Co., Ltd. (KRX: 249420)
South Korea
· Delayed Price · Currency is KRW
10,950
-440 (-3.86%)
Dec 20, 2024, 3:30 PM KST
Ildong Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Net Income | -10,655 | -78,928 | -141,585 | -99,705 | -13,019 | -13,444 | Upgrade
|
Depreciation & Amortization | 25,843 | 28,319 | 29,545 | 29,311 | 27,663 | 27,919 | Upgrade
|
Loss (Gain) From Sale of Assets | 2,582 | -1,133 | 282.22 | 101.53 | -2,029 | -1,891 | Upgrade
|
Asset Writedown & Restructuring Costs | 7,978 | 3,492 | 19,004 | 550.27 | 7,928 | 16,971 | Upgrade
|
Loss (Gain) From Sale of Investments | -439.72 | -439.72 | -2,325 | 862.82 | 5,222 | -84.34 | Upgrade
|
Loss (Gain) on Equity Investments | 273.85 | 0.36 | 0.54 | 1.67 | - | - | Upgrade
|
Stock-Based Compensation | 40.78 | -5.73 | 18.09 | 16.55 | 30.92 | - | Upgrade
|
Provision & Write-off of Bad Debts | -40.2 | -574.49 | -85.1 | -1,142 | -283.8 | 516.2 | Upgrade
|
Other Operating Activities | -3,843 | 24,140 | 56,020 | 60,178 | 16,763 | 18,123 | Upgrade
|
Change in Accounts Receivable | 4,738 | -2,089 | -1,407 | -1,857 | 13,386 | 6,901 | Upgrade
|
Change in Inventory | 2,413 | 13,852 | -15,532 | 6,617 | -19,036 | -28,537 | Upgrade
|
Change in Accounts Payable | 8,405 | 4,235 | 7,936 | 2,339 | -3,724 | 19,223 | Upgrade
|
Change in Other Net Operating Assets | -9,969 | -27,484 | -5,412 | -8,639 | -13,535 | -4,330 | Upgrade
|
Operating Cash Flow | 27,326 | -36,615 | -53,541 | -11,366 | 19,366 | 41,366 | Upgrade
|
Operating Cash Flow Growth | - | - | - | - | -53.18% | -37.93% | Upgrade
|
Capital Expenditures | -9,961 | -13,201 | -11,873 | -14,626 | -14,352 | -12,060 | Upgrade
|
Sale of Property, Plant & Equipment | 274.6 | 307.01 | 67.5 | 38.14 | 60 | 38.55 | Upgrade
|
Divestitures | 79.74 | - | - | 4,142 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -2,237 | -1,968 | -6,401 | -4,876 | -2,572 | -5,263 | Upgrade
|
Investment in Securities | 17,662 | -1,601 | -7,401 | -26,180 | -2,240 | 2,828 | Upgrade
|
Other Investing Activities | 21,100 | 1,025 | -842.62 | 1,133 | 196.66 | 930.04 | Upgrade
|
Investing Cash Flow | 19,800 | -20,360 | -26,435 | -43,368 | -18,403 | -14,026 | Upgrade
|
Short-Term Debt Issued | - | 84,500 | 23,000 | 141,600 | 198,600 | 163,600 | Upgrade
|
Long-Term Debt Issued | - | 29,250 | 17,000 | 99,400 | 42,000 | 20,000 | Upgrade
|
Total Debt Issued | 96,372 | 113,750 | 40,000 | 241,000 | 240,600 | 183,600 | Upgrade
|
Short-Term Debt Repaid | - | -48,700 | -20,000 | -133,600 | -207,600 | -147,600 | Upgrade
|
Long-Term Debt Repaid | - | -4,850 | -23,118 | -10,723 | -37,532 | -40,778 | Upgrade
|
Total Debt Repaid | -123,583 | -53,550 | -43,118 | -144,323 | -245,132 | -188,378 | Upgrade
|
Net Debt Issued (Repaid) | -27,211 | 60,200 | -3,118 | 96,677 | -4,532 | -4,778 | Upgrade
|
Issuance of Common Stock | 124.83 | 124.83 | - | 1,745 | - | - | Upgrade
|
Repurchase of Common Stock | -1,942 | -1,942 | - | - | -43.34 | -72.9 | Upgrade
|
Dividends Paid | -76.8 | -160 | -120 | - | - | -8,632 | Upgrade
|
Other Financing Activities | -366.08 | -70.4 | -49.31 | -0 | - | - | Upgrade
|
Financing Cash Flow | -30,836 | 58,152 | -3,287 | 104,316 | -4,576 | -13,484 | Upgrade
|
Foreign Exchange Rate Adjustments | 1.79 | -64.19 | -177.2 | 440.44 | -782.09 | 166.28 | Upgrade
|
Net Cash Flow | 16,292 | 1,112 | -83,440 | 50,022 | -4,395 | 14,022 | Upgrade
|
Free Cash Flow | 17,365 | -49,817 | -65,413 | -25,992 | 5,014 | 29,306 | Upgrade
|
Free Cash Flow Growth | - | - | - | - | -82.89% | -43.16% | Upgrade
|
Free Cash Flow Margin | 2.85% | -8.29% | -10.26% | -4.64% | 0.89% | 5.66% | Upgrade
|
Free Cash Flow Per Share | 623.26 | -1843.01 | -2483.08 | -1092.76 | 210.79 | 1231.84 | Upgrade
|
Cash Interest Paid | 13,500 | 10,412 | 5,643 | 4,041 | 2,711 | 3,289 | Upgrade
|
Cash Income Tax Paid | 426.52 | 724.88 | 2,524 | -290.57 | 2,439 | 1,355 | Upgrade
|
Levered Free Cash Flow | -172,370 | -14,968 | -159,418 | 101,154 | -1,447 | 28,990 | Upgrade
|
Unlevered Free Cash Flow | -163,065 | -5,765 | -153,300 | 107,752 | 1,471 | 32,256 | Upgrade
|
Change in Net Working Capital | 177,579 | -14,472 | 118,531 | -131,950 | 12,724 | -22,624 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.